ZX-7101A

· Nanjing Zenshine Pharmaceuticals

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ZX-7101A, covering 2024-11-04 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With Influenza [Phase 3]

See pricing